NCT01829217 2018-10-31
Sunitinib in Never-Smokers With Lung Adenocarcinoma
Dana-Farber Cancer Institute
Phase 2 Completed
Clinical Trials
6 trialsNCT01402089 2016-02-02
Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer Patients
Cantonal Hospital of St. Gallen
Phase 4 Completed
NCT00620347 2013-06-19
Sunitinib as a Second-line Treatment for Patients With Recurrent Small Cell Lung Cancer
National Cancer Center, Korea
Phase 2 Completed
NCT00430261 2010-10-06
Phase II Trial of Sunitinib in BAC or Never-Smokers With Any Lung Adenocarcinoma
Swedish Medical Center
Phase 2 Completed
NCT00113516 2010-05-18
A Study Of SU011248 As Therapy In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Pfizer
Phase 2 Completed
NCT00712504 2008-11-11
Study Of SU011248 In Combination With Docetaxel In Patients With Advanced Cancer
Pfizer
Phase 1 Completed